Heartflow, Inc. (HTFL) Payables and obligations
- Other obligations · latest quarter (USD): Value (m); Formula and calculation Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30..
- Payables · latest quarter (USD): Value $4.94M; Formula and calculation Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30..
- Deferred revenue · latest quarter (USD): Value $451.00K; Formula and calculation Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30..
- Other obligations · due within 1 year (USD): Value (m); Formula and calculation Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30..
Payables and obligations
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Other obligations · latest quarter (USD) | (m) | Total liabilities − borrowing debt − payables − total deferred revenue. Includes accruals, taxes, leases and other obligations; excludes the separately shown balances. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Payables · latest quarter (USD) | $4.94M | Amounts owed to suppliers, reported accounts payable. Period ending 2026-06-30. Reported amount: $4.94M |
| Deferred revenue · latest quarter (USD) | $451.00K | Current and noncurrent customer contract obligations; payments received before revenue is earned. Period ending 2026-06-30. $861.00K + $-410.00K ≈ $451.00K |
| Other obligations · due within 1 year (USD) | (m) | Reported other current liabilities. Excludes separately reported debt, payables and current deferred revenue. The saved current-quarter facts do not separately disclose taxes, payroll, leases or accruals. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Other obligations · due after 1 year (USD) | $715.00K | Reported other noncurrent liabilities minus the noncurrent deferred revenue they include (total customer contract obligations − current portion); a separately reported noncurrent deferred revenue line is not deducted. The saved current-quarter facts do not separately disclose taxes, leases or other accruals. Period ending 2026-06-30. $305.00K − $-410.00K ≈ $715.00K |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Total reported obligations | 64.74M USD | Liabilities |
| Borrowing debt | (m) | |
| Amounts owed to suppliers | 4.94M USD | Accounts Payable, Current |
| Total deferred revenue | 451.00K USD | Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Deferred revenue due within one year | 861.00K USD | Contract with Customer, Liability, Current |
| Deferred revenue due after one year | -410.00K USD | Contract with Customer, Liability · Contract with Customer, Liability, Current |
| Reported other obligations due within one year | (m) | |
| Reported other noncurrent obligations | 305.00K USD | Other Liabilities, Noncurrent |
| Deferred revenue included in other noncurrent obligations | -410.00K USD | Contract with Customer, Liability · Contract with Customer, Liability, Current |
Other obligations breakdown
- Other obligations · due within 1 year (USD)
- (m)
- Other obligations · due after 1 year (USD)
- $715.00K
Bonds and commercial paper are already included in Total debt. Other obligations include taxes, accrued expenses and operating/finance leases. Category amounts below are the issuer’s own tagged balances at the same quarter end; untagged categories are not shown.
| Category | Quarter ending 2026-06-30 |
|---|---|
| Operating lease obligations | $27.13M |
These categories are parts of the combined obligations, not additional deductions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Other obligations | Payables | Deferred revenue | Short-term obligations | Long-term obligations | Total reported obligations (USD) | Borrowing debt (USD) | Deferred revenue due within one year (USD) | Deferred revenue due after one year (USD) | Reported other noncurrent obligations (USD) | Deferred revenue included in other noncurrent obligations (USD) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $4.94M | $451.00K | (m) | $715.00K | $64.74M | (m) | $861.00K | $-410.00K | $305.00K | $-410.00K |
| 2026-03-31 | (m) | $5.75M | $386.00K | (m) | $1.52M | $58.31M | (m) | $1.58M | $-1.20M | $322.00K | $-1.20M |
| 2025-12-31 | (m) | $3.17M | $327.00K | (m) | $603.00K | $58.80M | (m) | $627.00K | $-300.00K | $303.00K | $-300.00K |
| 2025-09-30 | (m) | $1.96M | $149.00K | (m) | $665.00K | $109.83M | (m) | $520.00K | $-371.00K | $294.00K | $-371.00K |
| 2025-06-30 | (m) | $1.79M | $131.00K | (m) | $570.00K | $285.59M | (m) | $420.00K | $-289.00K | $281.00K | $-289.00K |
| 2024-12-31 | (m) | $2.87M | $182.00K | (m) | $1.07M | $209.62M | (m) | $1.04M | $-859.00K | $214.00K | $-859.00K |
| 2023-12-31 | (m) | (m) | $498.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $118.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |